We are live on ! Find out more
PCP

Perbak Capital Partners Portfolio holdings

AUM $406M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
+7.09%
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$442M
AUM Growth
+$307M
Cap. Flow
+$283M
Cap. Flow %
63.98%
Top 10 Hldgs %
46.35%
Holding
343
New
149
Increased
114
Reduced
12
Closed
68

Sector Composition

Rank Sector Weight
1 Healthcare 11.18%
2 Consumer Discretionary 8.49%
3 Industrials 7.79%
4 Technology 6.83%
5 Financials 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLYS icon
126
Qualys
QLYS
$4.99B
$735K 0.17%
5,146
+3,278
+175% +$434K
SANM icon
127
Sanmina
SANM
$9.83B
$729K 0.16%
+7,448
New +$615K
CRL icon
128
Charles River Laboratories
CRL
$11.3B
$728K 0.16%
+4,800
New +$640K
ZBRA icon
129
Zebra Technologies
ZBRA
$13.7B
$727K 0.16%
+2,359
New +$640K
CSL icon
130
Carlisle Companies
CSL
$15B
$726K 0.16%
1,943
+952
+96% +$353K
IYH icon
131
iShares US Healthcare ETF
IYH
$3.39B
$723K 0.16%
12,809
-14,538
-53% -$820K
PNR icon
132
Pentair
PNR
$10.6B
$713K 0.16%
6,946
-1,443
-17% -$135K
MLI icon
133
Mueller Industries
MLI
$14.8B
$709K 0.16%
+17,832
New +$673K
YELP icon
134
Yelp
YELP
$1.44B
$706K 0.16%
+20,598
New +$744K
HAL icon
135
Halliburton
HAL
$26.4B
$704K 0.16%
34,564
+20,144
+140% +$423K
LLY icon
136
Eli Lilly
LLY
$1.03T
$701K 0.16%
+899
New +$699K
PJT icon
137
PJT Partners
PJT
$4.33B
$695K 0.16%
+4,213
New +$612K
CAVA icon
138
CAVA Group
CAVA
$7.74B
$690K 0.16%
+8,189
New +$698K
NKE icon
139
Nike
NKE
$62.7B
$687K 0.16%
+9,673
New +$581K
GKOS icon
140
Glaukos
GKOS
$9.9B
$684K 0.15%
+6,623
New +$621K
GIS icon
141
General Mills
GIS
$19.4B
$678K 0.15%
+13,089
New +$722K
MTH icon
142
Meritage Homes
MTH
$4.72B
$664K 0.15%
+9,922
New +$658K
ALLE icon
143
Allegion
ALLE
$13.4B
$664K 0.15%
+4,608
New +$630K
HOLX
144
DELISTED
Hologic
HOLX
$661K 0.15%
+10,146
New +$608K
H icon
145
Hyatt Hotels
H
$16.6B
$660K 0.15%
+4,728
New +$590K
COP icon
146
ConocoPhillips
COP
$145B
$659K 0.15%
7,348
+3,817
+108% +$343K
WST icon
147
West Pharmaceutical
WST
$23.9B
$647K 0.15%
+2,955
New +$632K
TGT icon
148
Target
TGT
$65.6B
$634K 0.14%
6,422
+3,266
+103% +$314K
AWI icon
149
Armstrong World Industries
AWI
$7.37B
$631K 0.14%
+3,886
New +$577K
CUBE icon
150
CubeSmart
CUBE
$9.34B
$628K 0.14%
+14,773
New +$613K

Similar funds

Perbak Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Perbak Capital Partners held 343 positions worth $442M, up 228% from $135M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Perbak Capital Partners deployed $283M of net new capital in Q2 2025, opening 149 new positions and adding to 114 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 294,791 shares worth $53.6M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.7% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was iShares US Healthcare ETF, an estimated $820K trimmed.

  • Perbak Capital Partners's largest Q2 2025 buy was Invesco S&P 500 Equal Weight ETF: 294,791 shares worth $53.6M.
  • Perbak Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q2 2025, an estimated $18.7M increase.
  • Perbak Capital Partners's biggest Q2 2025 reduction was iShares US Healthcare ETF, cutting an estimated $820K.
  • Perbak Capital Partners fully exited 3M in Q2 2025, selling an estimated $3.17M.
  • Perbak Capital Partners's ten largest holdings make up 46% of its $442M portfolio in Q2 2025.
  • Perbak Capital Partners opened 149 new positions and closed 68 in Q2 2025.
  • Perbak Capital Partners's portfolio value rose 228% quarter-over-quarter to $442M.

Based on Perbak Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.